Mackenzie Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Mackenzie Financial's BMY Position: Q2 2026 in Review
Mackenzie Financial increased its Bristol-Myers Squibb (BMY) stake by 41% in Q2 2026, buying an estimated $34.4M and bringing the position to 2,064,284 shares worth $119M. The position accounts for 0.12% of the portfolio, ranked #146.
Mackenzie Financial first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Mackenzie Financial held 2,064,284 shares of Bristol-Myers Squibb worth $119M as of Q2 2026.
- Mackenzie Financial bought 598,851 Bristol-Myers Squibb shares in Q2 2026, an estimated $34.4M.
- Bristol-Myers Squibb made up 0.12% of Mackenzie Financial's portfolio in Q2 2026, its #146 holding.
- Mackenzie Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.